Antibacterial Agents TRIZ Cases

A cosmetic composition containing verbascoside, oligopeptide-10, and sulfonated shale oil delivers targeted anti-inflammatory and antibacterial action.

A synergistic microbicidal composition combines phenolic compounds with antimicrobial alcohols to achieve rapid microbial inactivation.

Co-extruding taurolidine into the suture matrix reduces manufacturing costs compared to Triclosan coatings while preserving mechanical integrity.

Chromosome recombineering integrates Shigella antigen genes into the Salmonella Ty21a vector to produce stable multivalent vaccine constructs.

Pyrimidine-sulfamides improve water solubility while maintaining pharmacokinetic reliability.

A synergistic mixture of organic acids and flavouring agents provides targeted antibacterial activity in animal feed applications.

Segmented linker molecules combine carbohydrate and aptamer modules to recruit natural antibodies, resolving synthesis complexity while enhancing stability.

A folate pathway PET tracer accumulates selectively in bacterial cells.

Pentasubstituted indolizines inhibit multiple Mycobacterium tuberculosis enzymes, reducing drug resistance and side effects.

Salicylanilides modulate host cell endosomal pH to block toxin entry, resolving the trade-off between infection cure and microbiota preservation.

T3SS inhibitor compounds block effector toxin secretion from Gram-negative bacteria using phenoxyacetamide derivatives.

A chitosan magnetic drug carrier guides active ingredients to the stomach lining using an external magnetic field.

Composite molecules block quorum sensing and NF-kB signaling to treat infections without triggering antibiotic resistance.

Lactobacillus johnsonii DSM 33288 inhibits pathogens, reducing infection risk without antibiotic resistance.

Tricyclic benzoxaborole compounds trap t-RNA via covalent bonding to overcome multidrug-resistant Gram-negative bacteria.

Novel peptides modulate innate immunity and reduce DPPIV activity, treating infections without inducing antimicrobial resistance.

A medical solution containing digestive enzyme inhibitors, antibiotics, and inflammatory lipid mediator binding proteins preserves intestinal motility.

Polysaccharide-poloxamer nanogels use polymyxin B to target gram-negative bacteria, reducing systemic antibiotic exposure and resistance development.

Continuous heating and dissolving equipment prevents thermal decomposition of doripenem by minimizing high-temperature exposure during dissolution.

Soluble prorenin receptor neutralizes harmful prorenin signaling to resolve the trade-off between hyperglycemia control and body weight gain.

Quinazolinone compounds with tailored substituents resolve the trade-off between broad inhibitory effect and precise isoform selectivity.

A chemical reaction between water and a reducing agent generates gas pressure to expel fluid active ingredients from device cavities.

A heme-haloperoxidase and amino alcohol composition generates singlet molecular oxygen to kill pathogenic microorganisms.

Segmented oil emulsion adjuvants with solid particulates reduce adverse effects while enhancing immune responses across species.

A trivalent immunogenic composition combines Mycoplasma hyopneumoniae, PCV2, and PRRS antigens into a single ready-to-use liquid formulation.

Formula I heteroaromatic compounds activate D1 receptors to alleviate schizophrenia symptoms while reducing side effects associated with prior agents.

Deleting VGF and O1L functions prevents ERK activation in normal cells, restricting viral growth to malignant tissue while preserving oncolytic efficacy.

Optimized pH and excipients maintain antibody stability while preserving therapeutic efficacy against autoimmune diseases.

Ultrasonic spray drying synthesizes bee venom nanoparticles that inhibit microbial growth while avoiding costly chemical reductants.

Merge potassium channel opener with reactive oxygen species catalyst to eliminate unpredictable tissue distribution from co-administration.

Portable device segments disinfectant and dilutant reservoirs to produce fixed dilution ratios upon user activation.

Combines lactate esters with benzaldehyde derivatives to deliver broad-spectrum antimicrobial activity in cosmetic formulations.

Covalently modified alginate polymers store and release nitric oxide to penetrate exopolysaccharide matrices, eradicating resistant biofilms.

Bactericidal monoclonal antibodies bind conformational epitopes in meningococcal proteins, replacing animal sacrifice with precise in vitro potency assessment.

Segmenting prostaglandin activity via specific substituents creates a selective EP2 agonist that avoids side effects from non-specific receptor activation.

Biodegradable microneedle arrays embed vaccines in polymer layers to penetrate skin barriers for targeted delivery.

Hot melt extrusion creates amorphous niclosamide dispersions that overcome low solubility and enable effective inhalation therapy.

Cleavable linkers mask antibiotics to reduce inflammatory side effects while maintaining antibacterial activity.

Segmenting histamine receptors isolates H4 activity, improving treatment specificity while managing development complexity.

Linking oxazolidinone and quinolone moieties via a spacer enables dual inhibition of protein synthesis and DNA gyrase to overcome multi-drug resistance.

Ultrasound waves sonicate infectious agents to release antigens, resolving the trade-off between vaccine safety and immune response strength.

Cytokine cocktails expand polyclonal gamma delta T cells, resolving the trade-off between lineage diversity and clinical cell quantities.

Novel non-steroidal compounds modulate glucocorticoid receptor activity to treat inflammatory disorders.

Quinoline derivatives inhibit F1F0 ATP synthase to deplete cellular energy, treating infections caused by antibiotic-resistant strains like MRSA.

PPAR-gamma agonists activate epithelial receptors to stimulate enteric defensin production.

CATH2 derivatives overcome antibiotic resistance in Streptococcus suis by combining direct bacterial killing with enhanced host immune response.

Heating solvate crystals yields stable anhydrous forms that resolve the trade-off between complex production processes and drug stability.

K5831 strain colonizes avian respiratory tracts to induce protective immunity against virulent infections.

Potassium hydrogen peroxymonosulfate eliminates pathogens through oxidation, avoiding the gastrointestinal damage caused by NSAIDs.

Monoclonal antibodies target conserved epitopes across botulinum neurotoxin serotypes to deliver high-affinity binding and neutralization.